SummitTX Capital »

Immunome shares owned by SummitTX Capital

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.7M 128k 21.48
2025-06-30 $100k 11k 9.30
2025-03-31 $141k 21k 6.73

More positions owned by SummitTX Capital

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Asml Holding N V N Y Registry Shs (ASML)
Eli Lilly & Co. (LLY)
MKS Instruments (MKSI)
Wal-Mart Stores (WMT)
Paypal Holdings (PYPL)
Applied Materials (AMAT)
Amazon (AMZN)
Anthem (ELV)
Costco Wholesale Corporation (COST)
UnitedHealth (UNH)
Meritage Homes Corporation (MTH)

View all positions for SummitTX Capital

Top funds holding Immunome

T. Rowe Price Investment Management
FMR
BlackRock
Point72 Asset Management
Vanguard Group
Redmile Group
Enavate Sciences GP
PRIMECAP Management Company
Leucadia National Corporation
State Street Corporation
EcoR1 Capital
Geode Capital Management
Toronto-Dominion Bank
Readystate Asset Management
Sofinnova Ventures

View all funds holding Immunome